|
ÃֽаúÇÐ ¿¬±¸, ¼±µµ °úÇÐÀÚ¿ÍÀÇ ³×Æ®¿öÅ©ÀÇ ±âȸ¿Í »ý¹° ¹°¸®ÇРƯ¼ºÈ¿¡ ´ëÇÑ ÆÁ°ú ±â¼úÀ» ¹è¿ï ¼ö ÀÖ´Â DiPIA (Biacore) 2018 ÄÁÆÛ·±½º¼´Â Biacore ½Ã½ºÅÛÀ» »ç¿ëÇϰí ÀÖ´Â ¼¼°è ¿©·¯ ³ª¶óÀÇ Çаè¿Í »ê¾÷°èÀÇ Àü¹®°úµé°ú ±âÃÊ ¿¬±¸ºÎÅÍ QC ¿µ¿ª¿¡¼ÀÇ ÀÌ¿ë »ç·Ê¿¡ ´ëÇØ ³íÀÇ ÇÒ ¼ö ÀÖ½À´Ï´Ù.
MAIN TOPIC
• Small molecules as therapeutics: from structure-activity relationship to clinical trials
• SPR-based assays for comparability and potency assessment
• Driving forward drug discovery with binding kinetics
• Use of SPR in process development of biotherapeutic
KEYNOTE SPEAKER
• Ute Jucknischke, Roche Diagnostics GmbH
Characterization of biotherapeutics
• Sumana Chandramouli, Ph.D., GSK Vaccines
Assessment of critical quality attributes of biotherapeutics
• Sanjay Panchal, Ph.D., AbbVie
Low molecular weight drug discovery and characterization
• Betsy Yakes, Ph.D., U.S. Food and Drug Administration
From basic research to advanced applications
ÀÚ¼¼È÷ º¸±â & µî·ÏÇϱâ
http://landing1.gehealthcare.com/Dipia-2018.html |